calendar
18,993 catalysts · 18,987 approval · 5,000 device 510k · 4,876 phase readout · 4,728 grant · 2,415 8k filing · 2,000 device pma
18,993 catalysts · 18,987 approval · 5,000 device 510k · 4,876 phase readout · 4,728 grant · 2,415 8k filing · 2,000 device pma
Sponsor: GLAXOSMITHKLINE. Form: TABLET. Route: ORAL
Sponsor: GLAXOSMITHKLINE. Form: TABLET. Route: ORAL
Sponsor: GLAXOSMITHKLINE. Form: TABLET. Route: ORAL
Sponsor: GLAXOSMITHKLINE. Form: TABLET. Route: ORAL
Sponsor: GLAXOSMITHKLINE. Form: TABLET. Route: ORAL
Sponsor: GLAXOSMITHKLINE. Form: TABLET. Route: ORAL
Sponsor: NOVARTIS. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: NOVARTIS. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: NOVARTIS. Form: TABLET. Route: ORAL
Sponsor: NOVARTIS. Form: TABLET. Route: ORAL
Sponsor: NOVARTIS. Form: SUSPENSION. Route: ORAL
Sponsor: NOVARTIS. Form: SUSPENSION. Route: ORAL
Sponsor: B BRAUN. Form: INJECTABLE. Route: INJECTION
Sponsor: NOVARTIS. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: NOVARTIS. Form: TABLET. Route: ORAL
Sponsor: NOVARTIS. Form: SUSPENSION. Route: ORAL
Sponsor: B BRAUN. Form: SOLUTION. Route: IRRIGATION
Sponsor: OZANTRI. Form: TABLET. Route: ORAL
Sponsor: OZANTRI. Form: TABLET. Route: ORAL
Sponsor: OZANTRI. Form: TABLET. Route: ORAL
Sponsor: OZANTRI. Form: TABLET. Route: ORAL
Sponsor: SANOFI AVENTIS US. Form: INJECTABLE. Route: INJECTION
Sponsor: SANOFI AVENTIS US. Form: INJECTABLE. Route: INJECTION
Sponsor: SANOFI AVENTIS US. Form: TABLET. Route: ORAL
Sponsor: SANOFI AVENTIS US. Form: CAPSULE. Route: ORAL
Sponsor: SANOFI AVENTIS US. Form: CAPSULE. Route: ORAL
Sponsor: JANSSEN PHARMS. Form: INJECTABLE. Route: INJECTION
Sponsor: IMPAX LABS INC. Form: CAPSULE, EXTENDED RELEASE. Route: ORAL
Sponsor: APIL. Form: TABLET. Route: ORAL
Sponsor: APIL. Form: TABLET. Route: ORAL
Sponsor: APIL. Form: TABLET. Route: ORAL
Sponsor: APIL. Form: TABLET. Route: ORAL
Sponsor: ACERTIS PHARMS. Form: CAPSULE. Route: ORAL
Sponsor: CHARTWELL. Form: TABLET. Route: ORAL
Sponsor: JANSSEN PHARMS. Form: CAPSULE. Route: ORAL
Sponsor: ACERTIS PHARMS. Form: CAPSULE. Route: ORAL
Sponsor: ACERTIS PHARMS. Form: CAPSULE. Route: ORAL
Sponsor: AUROBINDO PHARMA USA. Form: TABLET. Route: ORAL
Sponsor: JANSSEN PHARMS. Form: TABLET. Route: ORAL
Sponsor: LANNETT CO INC. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: ORGANON LLC. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: PURDUE PHARMA LP. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: PURDUE PHARMA LP. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: PURDUE PHARMA LP. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: PURDUE PHARMA LP. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: PURDUE PHARMA LP. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: JANSSEN PHARMS. Form: INJECTABLE. Route: INJECTION
Sponsor: ANI PHARMS. Form: TABLET. Route: ORAL
Sponsor: ANI PHARMS. Form: TABLET. Route: ORAL
Sponsor: ANI PHARMS. Form: TABLET. Route: ORAL